Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Enliven Therapeutics raised $90 million in a private placement financing to fund research and development of its clinical-stage product candidates.
Amount Raised
$90 Million
Round Type
Post-IPO Equity
Investors
Description
Enliven Therapeutics, Inc. announced a $90 million private placement financing, with participation from new and existing investors, including Commodore Capital, Fairmount, Venrock Healthcare Capital Partners, Rock Springs Capital, Logos Capital, Woodline Partners LP, and Acuta Capital Partners. The financing is expected to extend the cash runway into late 2026 and through multiple key clinical milestones for ELVN-001 and ELVN-002.
Fundz sees it the moment Enliven Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Enliven Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.